Publications by authors named "Michael A Harding"

Claim this Profile
U
Uromodulin and the study of urinary extracellular vesicles.
Michael A Harding, Hayrettin Yavuz, Annika Gathmann, Samantha Upson, Agnieszka Swiatecka-Urban

J Extracell Biol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of the DASH diet on the sodium-chloride cotransporter and aquaporin-2 in urinary extracellular vesicles.
Dana Bielopolski, Luca Musante, Ewout J Hoorn, Henrik Molina, Douglas Barrows, Michael A Harding

Am J Physiol Renal Physiol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD24 expression is important in male urothelial tumorigenesis and metastasis in mice and is androgen regulated.
Jonathan B Overdevest, Kristina H Knubel, Jason E Duex, Shibu Thomas, Matthew D Nitz, Michael A Harding

Proc Natl Acad Sci U S A· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD24 is an effector of HIF-1-driven primary tumor growth and metastasis.
Shibu Thomas, Michael A Harding, Steven C Smith, Jonathan B Overdevest, Matthew D Nitz

Cancer Res· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RREB1 transcription factor splice variants in urologic cancer.
Matthew D Nitz, Michael A Harding, Steven C Smith, Shibu Thomas, Dan Theodorescu

Am J Pathol· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RhoGDI signaling provides targets for cancer therapy.
Michael A Harding, Dan Theodorescu

Eur J Cancer· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Invasion and metastasis models for studying RhoGDI2 in bladder cancer.
Matthew D Nitz, Michael A Harding, Dan Theodorescu

Methods Enzymol· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RhoGDI2: a new metastasis suppressor gene: discovery and clinical translation.
Michael A Harding, Dan Theodorescu

Urol Oncol· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Profiling the evolution of human metastatic bladder cancer.
Brian E Nicholson, Henry F Frierson, Mark R Conaway, Jabed M Seraj, Michael A Harding

Cancer Res· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PTEN can inhibit in vitro organotypic and in vivo orthotopic invasion of human bladder cancer cells even in the absence of its lipid phosphatase activity.
John J Gildea, Mikael Herlevsen, Michael A Harding, Kathryn M Gulding, Christopher A Moskaluk

Oncogene· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional genomic comparison of lineage-related human bladder cancer cell lines with differing tumorigenic and metastatic potentials by spectral karyotyping, comparative genomic hybridization, and a novel method of positional expression profiling.
Michael A Harding, Karen C Arden, James W Gildea, John J Gildea, Elizabeth J Perlman

Cancer Res· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RhoGDI2 is an invasion and metastasis suppressor gene in human cancer.
John J Gildea, M Jabed Seraj, Gary Oxford, Michael A Harding, Garret M Hampton

Cancer Res· November 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of Ral A in epidermal growth factor receptor-regulated cell motility.
John J Gildea, Michael A Harding, M Jabed Seraj, Kay M Gulding, Dan Theodorescu

Cancer Res· February 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis